University of Alberta

Publications and E-portfolio

Model Overview

Kneteman N.M. and Mercer D.F. (2005) Mice With Chimeric Human Livers: Who Says Supermodels Have To Be Tall? Hepatology. 41(4) 703-706

Full Papers

Mercer D.F. et el. (2001) Hepatitis C virus replication in mice with chimeric human livers. Nature Medicine. 7(8):927-933

Kneteman N.M. et al. (2009) HCV796: a selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus. Hepatology. 49(3):745-752

Kneteman N.M. et al. (2006) Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application. Hepatology. 43(6):1346-1353

More Papers

Conferences

18th International Symposium on Hepatitis C Virus and Related Viruses, Seattle, Washington, US, September 8 - 12, 2011

Abstracts

4th Annual HCV Drug Discovery Conference at Drug Discovery Chemistry, San Diego, California, US, April 13 - 14, 2011

Abstract

Posters

HCV-796 displays potent antiviral activity in replicon and in chimeric mice infected with hepatitis C virus (2006) ICAAC Meeting, San Francisco, CA, US

More Posters